Dietmar Rudolf Thal

Active 2000–2025

148
Papers
34,167
Citations
83
h-index
143
i10-index

Citations

Citations per year for Dietmar Rudolf Thal1967: 1 citations1992: 1 citations1994: 1 citations1999: 1 citations2000: 4 citations2001: 7 citations2002: 25 citations2003: 36 citations2004: 58 citations2005: 51 citations2006: 84 citations2007: 102 citations2008: 160 citations2009: 166 citations2010: 177 citations2011: 207 citations2012: 267 citations2013: 295 citations2014: 397 citations2015: 506 citations2016: 605 citations2017: 621 citations2018: 567 citations2019: 1,513 citations2020: 1,702 citations2021: 1,692 citations2022: 1,603 citations2023: 1,305 citations2024: 2,088 citations2025: 1,187 citations2026: 43 citations1968–1991: no citations, so these years are not shown1993: no citations, so this year is not shown1995–1998: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 4,969 citing papers, 27.6% of this breakdownUnited Kingdom: 1,605 citing papers, 8.9% of this breakdownGermany: 1,270 citing papers, 7% of this breakdownChina: 1,256 citing papers, 7% of this breakdownSweden: 696 citing papers, 3.9% of this breakdownCanada: 681 citing papers, 3.8% of this breakdownItaly: 678 citing papers, 3.8% of this breakdownSpain: 630 citing papers, 3.5% of this breakdownNetherlands: 608 citing papers, 3.4% of this breakdownAustralia: 544 citing papers, 3% of this breakdownFrance: 543 citing papers, 3% of this breakdownJapan: 433 citing papers, 2.4% of this breakdown
0%27.6%Other 22.7%

Fields

  • Medicine67.1%
  • Neuroscience16.4%
  • Biochemistry, Genetics and Molecular Biology12.4%
  • Immunology and Microbiology0.9%
  • Computer Science0.7%
  • Environmental Science0.4%
  • Other2.1%

Topics

  • Alzheimer's disease research and treatments18%
  • Dementia and Cognitive Impairment Research8%
  • Neuroinflammation and Neurodegeneration Mechanisms5.2%
  • Parkinson's Disease Mechanisms and Treatments3.7%
  • Amyotrophic Lateral Sclerosis Research3.1%
  • Cholinesterase and Neurodegenerative Diseases2.3%
  • Other59.7%

Coauthors

All papers

Open in search
  1. Phases of Aβ-deposition in the human brain and its relevance for the development of AD

    Authors: , , , - Neurology 2002 cited by 3,503

  2. National Institute on Aging–Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approach

    Authors: , , , , , , , , , , , , , , , - Acta Neuropathologica 2011 cited by 2,925

  3. National Institute on Aging–Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease

    Authors: , , , , , , , , , , , , , , , , , - Alzheimer s & Dementia 2012 cited by 3,169

  4. Stages of the Pathologic Process in Alzheimer Disease: Age Categories From 1 to 100 Years

    Authors: , , , - Journal of Neuropathology & Experimental Neurology 2011 cited by 2,264

  5. Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Joshua A. Sonnen, Dietmar Rudolf Thal, John Q. Trojanowski, Juan C. Troncoso, Thomas Wısnıewskı, Randall L. Woltjer, Thomas G. Beach - Journal of Neuropathology & Experimental Neurology 2012 cited by 2,084

  6. Primary age-related tauopathy (PART): a common pathology associated with human aging

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Alberto Serrano‐Pozo, Michael L. Shelanski, Thor D. Stein, Masaki Takao, Dietmar Rudolf Thal, Jon B. Toledo, Juan C. Troncoso, Jean Paul Vonsattel, Charles L. White, Thomas Wısnıewskı, Randall L. Woltjer, Masahito Yamada, Peter T. Nelson - Acta Neuropathologica 2014 cited by 1,507

  7. The probabilistic model of Alzheimer disease: the amyloid hypothesis revised

    Authors: , , , , , , , , , , , , - Nature reviews. Neuroscience 2021 cited by 496

  8. Neuropathological consensus criteria for the evaluation of Lewy pathology in post-mortem brains: a multi-centre study

    Authors: , , , , , , , , , , , , , , , , , , , , , - Acta Neuropathologica 2021 cited by 276

  9. Pyroptosis in Alzheimer’s disease: cell type-specific activation in microglia, astrocytes and neurons

    Authors: , , , , , , , , - Acta Neuropathologica 2022 cited by 234

  10. MEG3 activates necroptosis in human neuron xenografts modeling Alzheimer’s disease

    Authors: , , , , , , , , , , , , , , , , , - Science 2023 cited by 214

  11. Neuroinflammation in Alzheimer disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Hannah Scheiblich, Guy C. Brown, Gary E. Landreth, Miguel Moutinho, Jaime Grutzendler, Diego Gómez‐Nicola, Róisín M. McManus, Katrin I. Andreasson, Christina Ising, Deniz Karabag, Darren J. Baker, Shane A. Liddelow, Alexei Verkhratsky, Malú G. Tansey, Alon Monsonego, Ludwig Aigner, Guillaume Dorothée, Klaus‐Armin Nave, Mikael Simons, Gabriela Constantin, Neta Rosenzweig, Alberto Pascual, Gabor C. Petzold, Jonathan Kipnis, Carmen Venegas, Marco Colonna, Jochen Walter, Andrea J. Tenner, M. Kerry O’Banion, Joern R. Steinert, Douglas L. Feinstein, Magdalena Sastre, Kiran Bhaskar, Soyon Hong, Dorothy P. Schafer, Todd E. Golde, Richard M. Ransohoff, David Morgan, John C.S. Breitner, Renzo Mancuso, Sean‐Patrick Riechers - Nature reviews. Immunology 2024 cited by 414

  12. LATE-NC staging in routine neuropathologic diagnosis: an update

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Melissa E. Murray, Liisa Myllykangas, Sukriti Nag, Janna H. Neltner, Kathy L. Newell, Robert A. Rissman, Yuko Saito, S. Ahmad Sajjadi, Katherine E. Schwetye, Andrew F. Teich, Dietmar Rudolf Thal, Sandra O. Tomé, Juan C. Troncoso, Shih‐Hsiu J. Wang, Charles L. White, Thomas Wısnıewskı, Hyun‐Sik Yang, Julie A. Schneider, Dennis W. Dickson, Manuela Neumann - Acta Neuropathologica 2022 cited by 176

  13. Interactions of pathological proteins in neurodegenerative diseases

    Authors: , , - Acta Neuropathologica 2017 cited by 427

  14. Aging-related tau astrogliopathy (ARTAG): harmonized evaluation strategy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Giorgio Giaccone, Kimmo J. Hatanpaa, Richard Heale, Patrick R. Hof, Monika Hofer, Tibor Hortobágyi, K. A. Jellinger, Gregory A. Jicha, Paul G. Ince, Julia Kofler, Enikò Kövari, Jillian J. Kril, David Mann, Radoslav Matěj, Ann C. McKee, Catriona McLean, Ivan Milenković, Thomas J. Montine, Shigeo Murayama, Edward B. Lee, Jasmin Rahimi, Roberta Diehl Rodriguez, Annemieke J.M. Rozemüller, Julie A. Schneider, Christian Schultz, William W. Seeley, Danielle Seilhean, Colin Smith, Fabrizio Tagliavini, Masaki Takao, Dietmar Rudolf Thal, Jon B. Toledo, Markus Tolnay, Juan C. Troncoso, Harry V. Vinters, Serge Weis, Stephen B. Wharton, Charles L. White, Thomas Wısnıewskı, John Woulfe, Masahito Yamada, Dennis W. Dickson - Acta Neuropathologica 2015 cited by 530

  15. Visualizing in deceased COVID-19 patients how SARS-CoV-2 attacks the respiratory and olfactory mucosae but spares the olfactory bulb

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Cell 2021 cited by 398

  16. Two Types of Sporadic Cerebral Amyloid Angiopathy

    Authors: , , , , , - Journal of Neuropathology & Experimental Neurology 2002 cited by 452

  17. Haploinsufficiency of TBK1 causes familial ALS and fronto-temporal dementia

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Alexander E. Volk, Petri Kursula, Karin M. Danzer, Peter Lichtner, Ivan Đikić, Thomas Meitinger, Albert C. Ludolph, Tim M. Strom, Peter M. Andersen, Jochen H. Weishaupt - Nature Neuroscience 2015 cited by 783

  18. Neuropathology and biochemistry of Aβ and its aggregates in Alzheimer’s disease

    Authors: , , , - Acta Neuropathologica 2014 cited by 321

  19. Astrocyte calcium dysfunction causes early network hyperactivity in Alzheimer’s disease

    Authors: , , , , , , , , , , , , , , , , , , , , , - Cell Reports 2022 cited by 143

  20. Restoring miR-132 expression rescues adult hippocampal neurogenesis and memory deficits in Alzheimer’s disease

    Authors: , , , , , , , , , , , , , , , , , , , , , - Cell stem cell 2021 cited by 192

  21. Staging of Neurofibrillary Pathology in Alzheimer's Disease: A Study of the BrainNet Europe Consortium

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Brain Pathology 2008 cited by 479

  22. TDP-43 is intercellularly transmitted across axon terminals

    Authors: , , , , , , , , , , , - The Journal of Cell Biology 2015 cited by 324

  23. TDP-43 pathology is associated with increased tau burdens and seeding

    Authors: , , , , , , , , , , , , , , , , - Molecular Neurodegeneration 2023 cited by 63

  24. Necrosome complex detected in granulovacuolar degeneration is associated with neuronal loss in Alzheimer’s disease

    Authors: , , , , , , , , , - Acta Neuropathologica 2019 cited by 168